Influence of lithium in vitro and in vivo on the catecholamine-sensitive cerebral adenylate cyclase systems.
Geisler
A
A
Klysner
R
R
Andersen
P H
PH
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000032:analysis; D000067956:Adenylyl Cyclase Inhibitors; D000818:Animals; D001921:Brain / Q000201:enzymology*; D002147:Calmodulin / Q000032:analysis; D002395:Catecholamines / Q000494:pharmacology*; D000242:Cyclic AMP / Q000378:metabolism; D006160:Guanosine Triphosphate / Q000494:pharmacology; D066298:In Vitro Techniques; D008094:Lithium / Q000494:pharmacology*; D011494:Protein Kinases / Q000032:analysis; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D011954:Receptors, Dopamine / Q000187:drug effects
D000067956:Adenylyl Cyclase Inhibitors; D002147:Calmodulin; D002395:Catecholamines; D011941:Receptors, Adrenergic; D011954:Receptors, Dopamine; D006160:Guanosine Triphosphate; D008094:Lithium; D000242:Cyclic AMP; D011494:Protein Kinases; D015105:3',5'-Cyclic-AMP Phosphodiesterases